121 related articles for article (PubMed ID: 14972003)
1. Iron overload and chronic hepatitis C: the role of HFE gene mutations.
García Buey L; González Mateos F
Rev Esp Enferm Dig; 2003 Dec; 95(12):819-28. PubMed ID: 14972003
[No Abstract] [Full Text] [Related]
2. The role of iron overload and HFE gene mutations in the era of pegylated interferon and ribavirin treatment of chronic hepatitis C.
Sikorska K; Stalke P; Izycka-Swieszewska E; Romanowski T; Bielawski KP
Med Sci Monit; 2010 Mar; 16(3):CR137-143. PubMed ID: 20190684
[TBL] [Abstract][Full Text] [Related]
3. HFE gene mutations prevent sustained virological response to interferon plus ribavirin in chronic hepatitis C patients with serum markers of iron overload.
Coelho-Borges S; Cheinquer H; Cheinquer N; Krug L; Ashton-Prolla P
Am J Gastroenterol; 2002 Jun; 97(6):1570-2. PubMed ID: 12094895
[No Abstract] [Full Text] [Related]
4. Hemochromatosis gene (HFE) mutations and cancer risk: expanding the clinical manifestations of hereditary iron overload.
Fargion S; Valenti L; Fracanzani AL
Hepatology; 2010 Apr; 51(4):1119-21. PubMed ID: 20373367
[No Abstract] [Full Text] [Related]
5. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
[TBL] [Abstract][Full Text] [Related]
6. HFE gene mutations and Wilson's disease in Sardinia.
Sorbello O; Sini M; Civolani A; Demelia L
Dig Liver Dis; 2010 Mar; 42(3):216-9. PubMed ID: 19640812
[TBL] [Abstract][Full Text] [Related]
7. Effects of iron and HFE mutations on response to therapy in chronic hepatitis C: an ironic interaction?
Alexander J; Kowdley KV
Gastroenterology; 2006 Nov; 131(5):1635-8. PubMed ID: 17067603
[No Abstract] [Full Text] [Related]
8. Iron overload in acute myeloid leukemia patients is not related to HFE and TFR2 gene mutations.
Veneri D; Franchini M; Zanetti F; Krampera M; de Matteis G; Pizzolo G
Haematologica; 2003 Sep; 88(9):1069-70. PubMed ID: 12969816
[No Abstract] [Full Text] [Related]
9. Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
Bonkovsky HL; Naishadham D; Lambrecht RW; Chung RT; Hoefs JC; Nash SR; Rogers TE; Banner BF; Sterling RK; Donovan JA; Fontana RJ; Di Bisceglie AM; Ghany MG; Morishima C;
Gastroenterology; 2006 Nov; 131(5):1440-51. PubMed ID: 17101320
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the HFE gene (H63D and C282Y) mutations in patients with iron overload, family members and controls from Antioquia, Northwest Colombia.
Avila-Gomez IC; Latorre-Sierra G; Restrepo-Gutierrez JC; Correa-Arango G; Jimenez-Del-Rio M; Velez-Pardo C
Clin Genet; 2008 Jan; 73(1):92-3. PubMed ID: 18005180
[No Abstract] [Full Text] [Related]
11. Genetic predisposition to iron overload: prevalence and phenotypic expression of hemochromatosis-associated HFE-C282Y gene mutation.
Distante S
Scand J Clin Lab Invest; 2006; 66(2):83-100. PubMed ID: 16537242
[No Abstract] [Full Text] [Related]
12. [Hereditary and acquired iron overload].
de Korwin JD
Nephrol Ther; 2006 Nov; 2 Suppl 5():S304-12. PubMed ID: 17373275
[TBL] [Abstract][Full Text] [Related]
13. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
Loria P; Lonardo A; Carulli N
Hepatology; 2004 Jun; 39(6):1748; author reply 1749. PubMed ID: 15185321
[No Abstract] [Full Text] [Related]
14. Iron status and HFE mutations in first-degree relatives of patients with sporadic porphyria cutanea tarda, in a Mediterranean area.
Garcia-Morillo JS; Lorca RR; Bernabeu-Wittel M; Garcia-Junco PS; Andreu EP; de la Fuente JC
J Intern Med; 2005 Apr; 257(4):389-90; author reply 391-3. PubMed ID: 15788010
[No Abstract] [Full Text] [Related]
15. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
[TBL] [Abstract][Full Text] [Related]
16. Iron, the HFE gene, and hepatitis C.
Eisenbach C; Gehrke SG; Stremmel W
Clin Liver Dis; 2004 Nov; 8(4):775-85, vii-viii. PubMed ID: 15464655
[TBL] [Abstract][Full Text] [Related]
17. Risk of iron overload in carriers of genetic mutations associated with hereditary haemochromatosis: UK Food Standards Agency workshop.
Singh M; Ashwell M; Sanderson P; Cade J; Moreton J; Fairweather-Tait S; Roe M; Marx JJ; Worwood M; Cook JD
Br J Nutr; 2006 Oct; 96(4):770-3. PubMed ID: 17010238
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C, iron status, and disease severity: relationship with HFE mutations.
Tung BY; Emond MJ; Bronner MP; Raaka SD; Cotler SJ; Kowdley KV
Gastroenterology; 2003 Feb; 124(2):318-26. PubMed ID: 12557137
[TBL] [Abstract][Full Text] [Related]
19. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
[TBL] [Abstract][Full Text] [Related]
20. Case report of a patient with non-alcoholic fatty liver disease, moderate iron overload who is homozygous for the S65C mutation in the HFE1 gene.
Bernard PH; Ged C; Faivre E; Legac G; Bioulac-Sage P; Cassaigne A; de Verneuil H
Eur J Med Genet; 2005; 48(2):195-8. PubMed ID: 16053912
[No Abstract] [Full Text] [Related]
[Next] [New Search]
